SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-058877
Filing Date
2014-09-19
Accepted
2014-09-19 18:50:10
Documents
1
Period of Report
2014-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6942
  Complete submission text file 0001209191-14-058877.txt   8609
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 FRANK W. BURR BLVD, SUITE 5 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD, SUITE 5 TEANECK NJ 07666 (201) 836-2308
Vidara Therapeutics Holdings LLC (Reporting) CIK: 0001619143 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35238 | Film No.: 141112824